NCT04045470
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Cutaneous T Cell Lymphoma
Explore clinical trials studying Cutaneous T Cell Lymphoma. Study availability and eligibility vary by location and protocol.
31 public trials
11 recruiting studies
Cutaneous T Cell Lymphoma trial results
NCT06860880
- Conditions
- Behavior, Blood Protein Disorders, Cardiovascular Diseases, +37 more
- Locations
-
- North Carolina Basnight Cancer Hospital Chapel Hill, North Carolina, United States
Recruiting
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
NCT05956041
- Conditions
- Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
NCT03932279
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
NCT05680558
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
NCT07356245
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Cutaneous T Cell Lymphoma, Graft Versus Host Disease, +25 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT07047885
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT06588868
- Conditions
- Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome, +13 more
- Locations
-
- AOU Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy
- IRCCS Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
- U.O.C. Dermatologia e Venereologia Universitaria - A.O.U. Policlinico Consorziale Bari, Italy
- Policlinico S.Orsola-Malpighi - Istituto di Ematologia Bologna, Italy
Recruiting
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
NCT06716658
- Conditions
- Cutaneous T Cell Lymphoma, Cutaneous T Cell Lymphoma (CTCL), Hematologic Diseases, +22 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, China Tianjin, Tianjin Municipality, China
- Institute of Hematology & Blood Diseases Hospital Tianjin, China
NCT04014374
- Conditions
- ATLL, Cutaneous T Cell Lymphoma, Hematologic Diseases, +16 more
- Locations
-
- CIBMTR Milwaukee, Wisconsin, United States